ACR appropriateness criteria® posttreatment follow-up of prostate cancer

Journal of the American College of Radiology

Volumn 8, Issue 12, 2011, Pages 863-871

  Casalino, David D ^a   Remer, Erick M ^b   Arellano, Ronald S ^c   Bishoff, Jay T ^d,e   Coursey, Courtney A ^f   Dighe, Manjiri ^g   Eggli, Douglas F ^h,i   Fulgham, Pat ^e,j   Israel, Gary M ^k   Lazarus, Elizabeth ^l   Leyendecker, John R ^m   Nikolaidis, Paul ^a   Papanicolaou, Nicholas ⁿ   Prasad, Srinivasa ^o   Ramchandani, Parvati ⁿ   Sheth, Sheila ^p   Vikram, Raghunandan ^q  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Intermountain Urological Institute   (United States)

^e American Urological Association   (United States)

^f EMORY UNIVERSITY HOSPITAL   (United States)

^g UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^h PENN STATE COLLEGE OF MEDICINE   (United States)

ⁱ Society of Nuclear Medicine   (United States)

^j PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l RHODE ISLAND HOSPITAL   (United States)

^m WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁿ HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^o UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^p JOHNS HOPKINS HOSPITAL   (United States)

^q UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

Appropriateness Criteria; imaging; posttreatment; prostate; prostate cancer

Indexed keywords

ACETIC ACID C 11; CAPROMAB PENDETIDE IN 111; FLUCICLOVINE F 18; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; PROSTATE SPECIFIC ANTIGEN;

ACR APPROPRIATENESS CRITERIA; ANALYSIS; ANDROGEN DEPRIVATION THERAPY; BONE RADIOGRAPHY; BONE SCINTISCANNING; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DELPHI STUDY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DISEASE SURVEILLANCE; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; IMAGING; MEDICAL EXPERT; MEDICAL LITERATURE; NOMOGRAM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEER REVIEW; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROSTATE CANCER; PROSTATECTOMY; REVIEW; THORAX RADIOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY; WHOLE BODY SCINTISCANNING;

EID: 84928096343     PISSN: 15461440     EISSN: 1558349X     Source Type: Journal    
DOI: 10.1016/j.jacr.2011.09.003     Document Type: Review

References (75)

1. C.R. Pound, O.W. Christens-Barry, and R.T. Gurganus Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy J Urol 162 1999 1337 1340 (Pubitemid 29428575)
2. D. Pucar, T. Sella, and H. Schoder The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery Curr Opin Urol 18 2008 87 97 (Pubitemid 350307537)
3. A.Y. Olsson, A. Bjartell, and H. Lilja Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues Int J Cancer 113 2005 290 297 (Pubitemid 39628320)
4. A.W. Partin, J.D. Pearson, and P.K. Landis Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases Urology 43 1994 649 659 (Pubitemid 24145607)
5. M.L. Cher, F.J. Bianco Jr, and J.S. Lam Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy J Urol 160 1998 1387 1391 (Pubitemid 29480523)
6. Z.A. Dotan, F.J. Bianco Jr, and F. Rabbani Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy BJU Int 23 2005 1962 1968 (Pubitemid 46211375)
7. C.J. Kane, C.L. Amling, and P.A. Johnstone Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy Urology 61 2003 607 611 (Pubitemid 36294200)
8. O.T. Okotie, W.J. Aronson, and J.A. Wieder Predictors of metastatic disease in men with biochemical failure following radical prostatectomy J Urol 171 2004 2260 2264 (Pubitemid 38625447)
9. T.K. Choueiri, R. Dreicer, and A. Paciorek A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy J Urol 179 2008 906 910
10. J.E. Freitas, R. Gilvydas, and J.D. Ferry The clinical utility of prostate-specific antigen and bone scintigraphy in prostate cancer follow-up J Nucl Med 32 1991 1387 1390
11. P.D. Miller, I. Eardley, and R.S. Kirby Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer Br J Urol 70 1992 295 298
12. M.K. Terris, A.S. Klonecke, and I.R. McDougall Utilization of bone scans in conjunction with prostate-specific antigen levels in the surveillance for recurrence of adenocarcinoma after radical prostatectomy J Nucl Med 32 1991 1713 1717
13. J.W. Turner, D.R. Hawes, and R.D. Williams Magnetic resonance imaging for detection of prostate cancer metastatic to bone J Urol 149 1993 1482 1484 (Pubitemid 23164550)
14. National Comprehensive Cancer Network The NCCN Clinical Practice Guidelines in Oncology prostate cancer V.3.2010 http://www.nccn.org/ professionals/physician-gls/PDF/prostate.pdf
15. American Urological Association Prostate-specific antigen best practice statement: 2009 update http://www.auanet.org/content/guidelines-and-quality- care/clinical-guidelines/main-reports/psa09.pdf
16. C.G. Salomon, M.E. Flisak, and M.C. Olson Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence Radiology 189 1993 713 719 (Pubitemid 23354483)
17. N.F. Wasserman, D.A. Kapoor, and W.C. Hildebrandt Transrectal US in evaluation of patients after radical prostatectomy Part II. Transrectal US and biopsy findings in the presence of residual and early recurrent prostatic cancer Radiology 185 1992 367 372
18. D.J. Lightner, P.H. Lange, and P.K. Reddy Prostate specific antigen and local recurrence after radical prostatectomy J Urol 144 1990 921 926 (Pubitemid 20324820)
19. C. Deliveliotis, T. Manousakas, and M. Chrisofos Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy World J Urol 25 2007 309 313
20. J.A. Connolly, K. Shinohara, and J.C. Presti Jr Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins Urology 47 1996 225 231 (Pubitemid 26075278)
21. L.S. Foster, P. Jajodia, and G. Fournier Jr The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy J Urol 149 1993 1024 1028 (Pubitemid 23133763)
22. A.K. Leventis, S.F. Shariat, and K.M. Slawin Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings Radiology 219 2001 432 439 (Pubitemid 32336357)
23. B. Shekarriz, J. Upadhyay, and D.P. Wood Jr Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage Urology 54 1999 1044 1048
24. F.M. Drudi, F. Giovagnorio, and A. Carbone Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomycomparison with MRI Ultraschall Med 27 2006 146 151
25. G.S. Sudakoff, R. Smith, and N.J. Vogelzang Color Doppler imaging and transrectal sonography of the prostatic fossa after radical prostatectomy: early experience AJR Am J Roentgenol 167 1996 883 888 (Pubitemid 26322235)
26. S. Tamsel, R. Killi, and E. Apaydin The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy Clin Radiol 61 2006 325 330
27. R.A. Older, M.C. Lippert, and S.B. Gay Computed tomography appearance of the prostatic fossa following radical prostatectomy Acad Radiol 2 1995 470 474
28. S. Kramer, J. Gorich, and H.W. Gottfried Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy Br J Radiol 70 1997 995 999 (Pubitemid 27464198)
29. R.H. Oyen, H.P. Van Poppel, and F.E. Ameye Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients Radiology 190 1994 315 322 (Pubitemid 24044226)
30. H. Hricak, H. Schoder, and D. Pucar Advances in imaging in the postoperative patient with a rising prostate-specific antigen level Semin Oncol 30 2003 616 634 (Pubitemid 37296787)
31. T. Sella, L.H. Schwartz, and P.W. Swindle Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging Radiology 231 2004 379 385 (Pubitemid 38552892)
32. J.M. Silverman, and T.L. Krebs MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy AJR Am J Roentgenol 168 1997 379 385 (Pubitemid 27051968)
33. E. Casciani, E. Polettini, and E. Carmenini Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy AJR Am J Roentgenol 190 2008 1187 1192 (Pubitemid 351684918)
34. S. Cirillo, M. Petracchini, and L. Scotti Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging Eur Radiol 19 2009 761 769
35. A. Sciarra, V. Panebianco, and S. Salciccia Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer Eur Urol 54 2008 589 600
36. T. Taoka, N.A. Mayr, and H.J. Lee Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy AJR Am J Roentgenol 176 2001 1525 1530 (Pubitemid 32510275)
37. M. Roach III, G. Hanks, and H. Thames Jr Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
38. E. Sala, S.C. Eberhardt, and O. Akin Endorectal MR imaging before salvage prostatectomy: tumor localization and staging Radiology 238 2006 176 183 (Pubitemid 43010594)
39. D. Pucar, H. Hricak, and A. Shukla-Dave Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence Int J Radiat Oncol Biol Phys 69 2007 62 69 (Pubitemid 47247515)
40. F.V. Coakley, H.S. Teh, and A. Qayyum Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience Radiology 233 2004 441 448 (Pubitemid 39423803)
41. D. Pucar, A. Shukla-Dave, and H. Hricak Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience Radiology 236 2005 545 553 (Pubitemid 41023438)
42. A.C. Westphalen, F.V. Coakley, and M. Roach III Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection Radiology 256 2010 485 492
43. M.A. Haider, P. Chung, and J. Sweet Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy Int J Radiat Oncol Biol Phys 70 2008 425 430
44. C.K. Kim, B.K. Park, and W. Park Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience Abdom Imaging 35 2010 246 252
45. O. Rouviere, O. Valette, and S. Grivolat Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumorcorrelation with biopsy findings Urology 63 2004 922 927 (Pubitemid 38596680)
46. C.K. Kim, B.K. Park, and H.M. Lee Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI Appl Radiat Isot 29 2009 391 397
47. R.A. Castellino Retroperitoneal and pelvic lymph node imaging Cancer 67 1991 1219 1222
48. H.C. Ruckle, G.G. Klee, and J.E. Oesterling Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy Mayo Clin Proc 69 1994 69 79 (Pubitemid 24016919)
49. V. Fradet, J. Kurhanewicz, and J.E. Cowan Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging Radiology 256 2010 176 183
50. N.J. van As, N.M. de Souza, and S.F. Riches A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance Eur Urol 56 2009 981 987
51. A.A. Elgamal, M.J. Troychak, and G.P. Murphy ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients Prostate 37 1998 261 269 (Pubitemid 28524659)
52. D. Kahn, R.D. Williams, M.J. Manyak The ProstaScint Study Group 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy J Urol 159 1998 2041 2046
53. J.D. Petronis, F. Regan, and K. Lin Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer Clin Nucl Med 23 1998 672 677 (Pubitemid 28487326)
54. S. Wilkinson, and G. Chodak The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy J Urol 172 2004 133 136 (Pubitemid 41615054)
55. S.L. Liauw, R.R. Weichselbaum, and G.P. Zagaja Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease? Int J Radiat Oncol Biol Phys 71 2008 1316 1321
56. S.N. Nagda, N. Mohideen, and S.S. Lo Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 67 2007 834 840 (Pubitemid 46215867)
57. H. Schoder, K. Herrmann, and M. Gonen 2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy Clin Cancer Res 11 2005 4761 4769 (Pubitemid 41557196)
58. P.D. Shreve, H.B. Grossman, and M.D. Gross Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose Radiology 199 1996 751 756
59. N. Oyama, T.R. Miller, and F. Dehdashti 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse J Nucl Med 44 2003 549 555 (Pubitemid 39663421)
60. S. Albrecht, F. Buchegger, and D. Soloviev (11)C-acetate PET in the early evaluation of prostate cancer recurrence Eur J Nucl Med Mol Imaging 34 2007 185 196 (Pubitemid 46147501)
61. P. Castellucci, C. Fuccio, and C. Nanni Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 2009 1394 1400
62. I.J. de Jong, J. Pruim, and P.H. Elsinga 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer Eur Urol 44 2003 32 38
63. L. Rinnab, J. Simon, and R.E. Hautmann [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy World J Urol 27 2009 619 625
64. V. Scattoni, M. Picchio, and N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429 (Pubitemid 46963456)
65. M. Cimitan, R. Bortolus, and S. Morassut [(18)F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 33 2006 1387 1398 (Pubitemid 44885404)
66. M. Heinisch, A. Dirisamer, and W. Loidl Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml? Mol Imaging Biol 8 2006 43 48 (Pubitemid 44193401)
67. D.B. Husarik, R. Miralbell, and M. Dubs Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 253 263
68. D.M. Schuster, J.R. Votaw, and P.T. Nieh Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma J Nucl Med 48 2007 56 63 (Pubitemid 47555376)
69. R. Nunez, H.A. Macapinlac, and H.W. Yeung Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer J Nucl Med 43 2002 46 55 (Pubitemid 34101187)
70. S.W. Heijmink, J.J. Futterer, and T. Hambrock Prostate cancer: body-array versus endorectal coil MR imaging at 3 Tcomparison of image quality, localization, and staging performance Radiology 244 2007 184 195 (Pubitemid 46981973)
71. C.K. Kim, and B.K. Park Update of prostate magnetic resonance imaging at 3 T J Comput Assist Tomogr 32 2008 163 172 (Pubitemid 351489432)
72. J. Kurhanewicz, D.B. Vigneron, and H. Hricak Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging Radiology 200 1996 489 496 (Pubitemid 26249904)
73. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499 (Pubitemid 36706536)
74. American College of Radiology Manual on contrast media v7 http://www.acr.org/SecondaryMainMenuCategories/quality-safety/contrast-manual. aspx
75. ®: radiation dose assessment introduction http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/app-criteria/RRLInformation.aspx Accessed August 30, 2011